Source link : https://www.newshealth.biz/health-news/watershed-moment-semaglutide-effective-in-mash/
SAN DEIGO — Semaglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist, appears to safely and effectively treat metabolic dysfunction–associated steatohepatitis (MASH) among patients with moderate to advanced liver fibrosis, according to interim results from a phase 3 trial. At 72 weeks, a 2.4-mg once-weekly subcutaneous dose of semaglutide demonstrated superiority compared with placebo for the […]
Author : News Health
Publish date : 2024-11-21 10:40:50
Copyright for syndicated content belongs to the linked Source.
inHealth